Related Experiment Video
Updated: Aug 9, 2026
08:06
Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation
Published on: May 5, 2023
Gene transfer approaches for gynecological diseases
Mari Raki1, Daniel T Rein, Anna Kanerva
1Cancer Gene Therapy Group, Rational Drug Design Program, University of Helsinki, 00014 Helsinki, Finland.
Summary
Gene transfer offers new hope for gynecological diseases, particularly cancers. While safe in trials, improving gene delivery and tumor penetration remains key for effective treatment.
Area of Science:
- Gynecological Oncology
- Gene Therapy
- Translational Medicine
Background:
- Gene transfer is a promising therapeutic strategy for diseases resistant to conventional treatments.
- Significant research has focused on gynecological cancers, especially ovarian cancer, due to urgent unmet needs.
- Early clinical trials demonstrate the safety of gene transfer approaches.
Purpose of the Study:
- To review current and emerging gene transfer applications for gynecological diseases.
- To highlight advancements in gene therapy for gynecological conditions.
- To discuss the potential of gene transfer in treating gynecological cancers.
Main Methods:
- Review of preclinical and clinical studies on gene transfer for gynecological diseases.
- Analysis of gene transfer vector development and delivery strategies.
- Examination of challenges in achieving therapeutic efficacy within complex tumor microenvironments.
Main Results:
- Gene transfer has shown safety in early-phase clinical trials for gynecological diseases.
- Efficacy of current gene transfer strategies remains largely limited.
- Key challenges involve enhancing vector delivery, selectivity, and tumor penetration.
Conclusions:
- Gene transfer holds significant potential for treating gynecological diseases, including cancers.
- Further advancements in vector technology are crucial for improving therapeutic outcomes.
- Overcoming challenges in delivery and spread is essential for clinical success.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:53Transgenic Organisms
Overview
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
00:49What is Genetic Engineering?
Overview
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.